The establishment of a Viral Vector Core Facility at the Department of Gene Therapy is a project of InnoSÜD, a cluster that was formed between Ulm University and the Universities of Applied Sciences in Ulm, Neu-Ulm and Biberach. InnoSÜD sets a focus on innovation and transfer and comprises the four sectors energy, mobility, health & biotechnology and transformation. It is sponsored by the Federal Ministry of Education and Research in the frame of the funding initiative "Innovative Hochschule".

During the 5 years funding period (2018-2022) it is our goal to develop the infrastructure and standard operation procedures (SOPs) to provide adeno-, adeno-associated- and lentiviral vector preparations in high quality. Thereby we want to support and connect research at academia and industry. Consulting and training on request will complete our portfolio once SOPs have been set up.

If you have any questions or want to learn more about us, please contact

Dr. Astrid Kritzinger, 0731 500 46118, astrid.kritzinger[a]uni-ulm.de

https://innosued.de/gesundheit_biotechnologie/viral-vector-core-facility/